Atomi Financial Group, Inc. Bridge Bio Pharma, Inc. Transaction History
Atomi Financial Group, Inc.
- $2.65 Trillion
- Q2 2025
A detailed history of Atomi Financial Group, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Atomi Financial Group, Inc. holds 14,786 shares of BBIO stock, worth $936,988. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,786
Previous 14,366
2.92%
Holding current value
$936,988
Previous $497 Million
28.56%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding BBIO
# of Institutions
412Shares Held
187MCall Options Held
11.3MPut Options Held
1.93M-
Viking Global Investors LP18.6MShares$1.18 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.04 Billion0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$840 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$789 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$588 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.39B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...